Trial Profile
Safety of palbociclib in patients with ER positive metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jun 2018
Price :
$35
*
At a glance
- Drugs Palbociclib (Primary) ; Aromatase inhibitors; Fulvestrant
- Indications Advanced breast cancer
- Focus Adverse reactions
- 12 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology